Gynoxin

Gynoxin is a vaginal antifungal medication whose active ingredient is fenticonazole nitrate. It is supplied in a vaginal formulation, with the specific strength not disclosed in the public data. Classified as an imidazole antifungal, Gynoxin is marketed in the European Union and is intended for the treatment of fungal infections of the vagina. The product works by inhibiting ergosterol synthesis in fungal cells and maintaining cell membrane integrity.

Gynoxin is indicated for the topical treatment of fungal infections affecting the female genital tract, particularly when caused by Candida species.

- Vulvovaginal candidiasis caused by Candida species. - Acute yeast infection of the vagina. - Maintenance therapy to reduce recurrence of vaginal yeast infections. - Treatment of mixed bacterial‑fungal vaginitis when a fungal component is confirmed. - Adjunctive therapy in patients with resistant Candida strains, as directed by a healthcare professional. - Consideration for patients with diabetes mellitus who experience recurrent yeast infections. - Application following systemic antifungal therapy to eradicate residual vaginal colonization.

Side effects reported with vaginal fenticonazole nitrate are generally mild, but some reactions may require medical attention.

Common: - Local irritation or burning sensation at the application site. - Vaginal itching or mild discomfort. - Unusual vaginal discharge that is watery or slightly colored. - Mild abdominal cramps or pelvic pressure. - Temporary increase in vaginal discharge volume.

Serious: - Severe allergic reaction such as swelling of the face, lips, tongue, or throat. - Persistent or worsening vaginal irritation with ulceration. - Signs of systemic infection like fever, chills, or malaise. - Development of a new rash or hives elsewhere on the body. - Signs of liver dysfunction such as jaundice, dark urine, or abdominal swelling.

Before using Gynoxin, certain precautions should be considered to ensure safe and effective treatment.

- Confirm the diagnosis of a fungal infection before initiating therapy. - Avoid using the product if you have a known hypersensitivity to fenticonazole or other imidazole antifungals. - Do not apply the medication if the vaginal mucosa is severely inflamed, ulcerated, or bleeding. - Consult a healthcare professional before use during pregnancy, lactation, or if you plan to become pregnant. - Keep the applicator clean and follow the recommended insertion technique to reduce the risk of secondary infection. - Report any persistent irritation, unusual discharge, or systemic symptoms to a clinician promptly.

Vaginal fenticonazole nitrate may interact with other medicines or substances applied to the genital area.

Avoid: - Concurrent use of other topical antifungal agents without medical advice. - Simultaneous application of intravaginal spermicides or lubricants that contain irritants. - Use of vaginal douches or cleansing solutions immediately before or after application.

Use with caution: - Systemic azole antifungals (e.g., fluconazole) as combined therapy may increase the risk of adverse effects. - Hormonal contraceptives inserted vaginally, as absorption could be altered. - Products containing alcohol or essential oils that may irritate the mucosa. - Any medication that affects liver enzymes, pending clinical evaluation. - Topical corticosteroids in the vaginal area, as they may mask irritation signs.